Medpace Holdings, Inc. (NASDAQ:MEDP) Major Shareholder Medpace Investors, Llc Acquires 57,426 Shares
Medpace Holdings, Inc. (NASDAQ:MEDP) Major Shareholder Medpace Investors, Llc Acquires 57,426 Shares
Medpace Holdings, Inc. (NASDAQ:MEDP – Get Rating) major shareholder Medpace Investors, Llc acquired 57,426 shares of Medpace stock in a transaction dated Thursday, September 22nd. The shares were acquired at an average price of $154.59 per share, with a total value of $8,877,485.34. Following the completion of the transaction, the insider now owns 6,483,019 shares of the company's stock, valued at approximately $1,002,209,907.21. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.
梅德佩斯控股公司(納斯達克代碼:MEDP-GET評級)大股東梅德佩斯投資者有限責任公司在日期為9月22日星期四的交易中收購了梅德佩斯公司57,426股股票。這些股票是以每股154.59美元的平均價格收購的,總價值為8,877,485.34美元。交易完成後,這位內部人士現在擁有該公司6,483,019股股票,價值約1,002,209,907.21美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站。持有公司10%以上股份的大股東被要求披露他們與美國證券交易委員會的交易。
Medpace Investors, Llc also recently made the following trade(s):
Medace Investors,LLC最近還進行了以下交易:
- On Monday, September 19th, Medpace Investors, Llc acquired 94,119 shares of Medpace stock. The shares were acquired at an average price of $153.48 per share, with a total value of $14,445,384.12.
- On Tuesday, September 13th, Medpace Investors, Llc bought 62,516 shares of Medpace stock. The stock was purchased at an average price of $157.12 per share, with a total value of $9,822,513.92.
- 9月19日,星期一,Medace Investors,LLC收購了Medace股票94,119股。這些股票是以每股153.48美元的平均價格收購的,總價值為14,445,384.12美元。
- 9月13日,星期二,Medace Investors,LLC購買了62,516股Medace股票。這隻股票是以每股157.12美元的平均價格購買的,總價值為9822513.92美元。
Medpace Stock Performance
Medace股票表現
Shares of NASDAQ MEDP traded down $9.45 during trading on Friday, hitting $145.38. The company had a trading volume of 624,044 shares, compared to its average volume of 345,257. The company has a market cap of $4.51 billion, a P/E ratio of 24.82 and a beta of 1.47. Medpace Holdings, Inc. has a 52 week low of $126.94 and a 52 week high of $231.00. The business's 50-day moving average is $161.45 and its 200 day moving average is $152.75.
納斯達克的股價在週五的交易中下跌了9.45美元,跌至145.38美元。該公司的成交量為624,044股,而其平均成交量為345,257股。該公司市值為45.1億美元,市盈率為24.82倍,貝塔係數為1.47。Medace Holdings,Inc.的52周低點為126.94美元,52周高位為231.00美元。該業務的50日移動均線切入位在161.45美元,200日移動均線切入位在152.75美元。
Institutional Inflows and Outflows
機構資金流入和流出
Several institutional investors have recently modified their holdings of the stock. Wasatch Advisors Inc. raised its stake in Medpace by 12.1% during the 1st quarter. Wasatch Advisors Inc. now owns 2,728,392 shares of the company's stock valued at $446,338,000 after purchasing an additional 294,103 shares during the period. Boston Trust Walden Corp raised its stake in Medpace by 38.2% during the 1st quarter. Boston Trust Walden Corp now owns 674,994 shares of the company's stock valued at $110,423,000 after purchasing an additional 186,518 shares during the period. Riverbridge Partners LLC raised its stake in Medpace by 44.1% during the 2nd quarter. Riverbridge Partners LLC now owns 481,404 shares of the company's stock valued at $72,052,000 after purchasing an additional 147,225 shares during the period. Loomis Sayles & Co. L P raised its stake in Medpace by 149.5% during the 4th quarter. Loomis Sayles & Co. L P now owns 233,242 shares of the company's stock valued at $50,763,000 after purchasing an additional 139,767 shares during the period. Finally, Echo Street Capital Management LLC raised its stake in Medpace by 18.4% during the 1st quarter. Echo Street Capital Management LLC now owns 695,336 shares of the company's stock valued at $113,750,000 after purchasing an additional 108,133 shares during the period. Institutional investors own 83.97% of the company's stock.
幾家機構投資者最近調整了對該股的持股比例。Wasatch Advisors Inc.在第一季度將其在MedPace的持股比例提高了12.1%。Wasatch Advisors Inc.在此期間又購買了294,103股票,現在擁有2,728,392股該公司股票,價值446,338,000美元。波士頓信託沃爾登公司在第一季度將其在Medace的持股增加了38.2%。波士頓信託沃爾登公司目前擁有674,994股該公司股票,價值110,423,000美元,在此期間又購買了186,518股。Riverbridge Partners LLC在第二季度將其在MedPace的持股增加了44.1%。Riverbridge Partners LLC現在擁有481,404股該公司的股票,價值72,052,000美元,在此期間又購買了147,225股。Loomis Sayles&Co.L P在第四季度將其在MedPace的持股比例提高了149.5%。Loomis Sayles&Co.L P現在持有233,242股該公司股票,價值50,763,000美元,在此期間又購買了139,767股。最後,Echo Street Capital Management LLC在第一季度將其在MedPace的持股增加了18.4%。Echo Street Capital Management LLC現在擁有該公司695,336股股票,價值113,750,000美元,在此期間又購買了108,133股。機構投資者持有該公司83.97%的股票。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
A number of research firms have weighed in on MEDP. StockNews.com downgraded Medpace from a "buy" rating to a "hold" rating in a research report on Thursday, September 8th. UBS Group began coverage on Medpace in a research report on Wednesday, September 7th. They issued a "sell" rating and a $142.00 target price for the company.
一些研究公司已經對MEDP發表了看法。在9月8日週四的一份研究報告中,StockNews.com將MedPace的評級從“買入”下調至“持有”。瑞銀集團於9月7日星期三在一份研究報告中開始對MedPace進行報道。他們對該公司的評級為“賣出”,目標價為142.00美元。
About Medpace
關於MedPace
(Get Rating)
(獲取評級)
Medpace Holdings, Inc provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.
Medace控股公司在北美、歐洲和亞洲提供以臨牀研究為基礎的藥物和醫療器械開發服務。它在不同的治療領域提供一整套服務,支持從第一階段到第四階段的臨牀開發過程。該公司還為製藥、生物技術和醫療器械行業提供臨牀開發服務;開發計劃設計、協調中心實驗室、項目管理、法規事務、臨牀監測、數據管理和分析、藥物警戒新藥申請提交以及上市後臨牀支持服務。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Medpace (MEDP)
- Why Does Tesla Stock Remain Resilient?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 免費獲取StockNews.com關於MedPace的研究報告(MEDP)
- 為什麼特斯拉的股票保持彈性?
- CrowdStrike是否會從增加每股收益指引中獲得提振?
- 好市多盈利後價格疲軟是買入的好時機嗎?
- 需要關注的2只半導體類股走勢逆轉
- 小盤股的裁員是樓市的晴雨表嗎?
Receive News & Ratings for Medpace Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medpace and related companies with MarketBeat.com's FREE daily email newsletter.
接受Medace Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收對MedPace和相關公司的最新新聞和分析師評級的每日簡要摘要。